XSHE
002551
Market cap426mUSD
Oct 09, Last price
3.44CNY
1D
1.78%
1Q
19.44%
Jan 2017
-73.44%
IPO
-50.88%
Name
Shenzhen Glory Medical Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Shenzhen Glory Medical Co., Ltd., founded in 1998 and based in Shenzhen, China, offers integrated solutions for hospital development and medical systems across the nation. The company's operations encompass the full spectrum of hospital construction, from initial planning and design to project management and execution, as well as the installation of specialized medical engineering. It also engages in the development of medical software. Beyond this, Glory Medical supplies a range of medical protective gear and consumables, including non-woven surgical gowns, medical surgical kits, disposable protective clothing, isolation gowns, masks, and various surgical supplies. The company provides advanced medical information solutions such as digital operating theaters, surgical training systems, remote consultation platforms, mobile digital video stations, centralized management systems, and digital emergency response platforms. Furthermore, its extensive service offerings include facility and system management, medical equipment maintenance, patient guidance, caregiver assistance, logistics, cleaning, landscaping, security, catering, and parking administration.
Key people
Yong You
Chief Financial Officer · since 2021
Guitian Liang
Vice Chairman of the Board, Deputy General Manager · since 2012
Li Song
Deputy General Manager · since 2021
Deputy General Manager, Secretary of the Board · since 2013
Ning Huang
Director · since 2008
Junhua Liang
Director · since 2021
Guiqiu Liang
Chairman of the Board, General Manager · since 2013
Xichun Yu
Director · since 2021
Jierui Zhang
Staff Elected Director · since 2025
Qiong Long
Independent Director · since 2021
Independent Director · since 2008
Junfeng Zhao
Independent Director · since 2024
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2022‑00 | 2021‑12 | 2020‑12 | 2020‑00 | 2019‑12 | 2019‑00 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||||||
Revenues | ||||||||||||||
Cost of revenue | ||||||||||||||
Unusual Expense (Income) | ||||||||||||||
NOPBT | ||||||||||||||
NOPBT Margin | ||||||||||||||
Operating Taxes | ||||||||||||||
Tax Rate | ||||||||||||||
NOPAT | ||||||||||||||
Net income | ||||||||||||||
Dividends | ||||||||||||||
Dividend yield | ||||||||||||||
Proceeds from repurchase of equity | ||||||||||||||
BB yield | ||||||||||||||
| Debt | ||||||||||||||
Debt current | ||||||||||||||
Long-term debt | ||||||||||||||
Deferred revenue | ||||||||||||||
Other long-term liabilities | ||||||||||||||
Net debt | ||||||||||||||
| Cash flow | ||||||||||||||
Cash from operating activities | ||||||||||||||
CAPEX | ||||||||||||||
Cash from investing activities | ||||||||||||||
Cash from financing activities | ||||||||||||||
FCF | ||||||||||||||
| Balance | ||||||||||||||
Cash | ||||||||||||||
Long term investments | ||||||||||||||
Excess cash | ||||||||||||||
Stockholders' equity | ||||||||||||||
Invested Capital | ||||||||||||||
ROIC | ||||||||||||||
ROCE | ||||||||||||||
| EV | ||||||||||||||
Common stock shares outstanding | ||||||||||||||
Price | ||||||||||||||
Market cap | ||||||||||||||
EV | ||||||||||||||
EBITDA | ||||||||||||||
EV/EBITDA | ||||||||||||||
Interest | ||||||||||||||
Interest/NOPBT | ||||||||||||||